-
A new tool to predict physical health risks in young people with psychosis
A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with... Read more -
Q&A: How small steps can help GLP-1 users build healthier habits
A Stanford study shows simple digital prompts can motivate people taking GLP-1 medications to make lifestyle changes. It's a simple... Read more -
Study links higher asprosin to less weight gain after menopause
Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the... Read more -
Circadian rhythm drives metabolic dysfunction in fat cells, study finds
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director... Read more -
Mediterranean diet protects against fractures while calorie restriction increases bone breakdown, study finds
A Mediterranean diet can significantly lower the risk of hip and overall fractures, according to a major new review from... Read more -
Some patients keep weight off with fewer GLP-1 injections, study finds
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less... Read more -
Anti-obesity treatment could cost as little as $3 per month: Study
A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off... Read more -
Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks... Read more -
Predictors of prediabetes/type 2 diabetes mellitus identified among U.S. adolescents
Male gender, younger age, and waist-to-height ratio are independent predictors of prediabetes/type 2 diabetes mellitus (T2DM) among U.S. adolescents, according... Read more -
Twenty percent of eligible youth prescribed GLP-1 receptor agonists
Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher... Read more -
Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last
A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But... Read more -
How gut bacteria and diet can reprogram fat to burn more energy
Scientists at City of Hope and the Broad Institute and Keio University have discovered how specific gut bacteria work together... Read more -
No more weekly injections? How lettuce cells could deliver GLP-1 pills
Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as a new oral... Read more -
GLP-1 weight-loss drugs comparably effective across age, race and starting weight
Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among patients... Read more -
Emotions drive our eating choices
New research from Flinders University has revealed why many people struggle to stick to their dieting goals, particularly when their... Read more
